← Back to All US Stocks

PACS Group, Inc. (PACS) Stock Fundamental Analysis & AI Rating 2026

PACS NYSE Services-Skilled Nursing Care Facilities DE CIK: 0002001184
Recently Updated • Analysis: Apr 13, 2026 • SEC Data: 2025-12-31
HOLD
65% Conf
Pending
Analysis scheduled

📊 PACS Key Takeaways

Revenue: $5.3B
Net Margin: 3.6%
Free Cash Flow: $404.2M
Current Ratio: 1.07x
Debt/Equity: 0.37x
EPS: $1.22
AI Rating: HOLD with 65% confidence
PACS Group, Inc. (PACS) receives a HOLD rating with 65% confidence from our AI fundamental analysis based on SEC 10-K filings. With revenue of $5.3B, net profit margin of 3.6%, and return on equity (ROE) of 20.2%, PACS Group, Inc. demonstrates mixed fundamentals in the Services sector. Below is our complete PACS stock analysis for 2026.

Is PACS Group, Inc. (PACS) a Good Investment?

Claude

PACS demonstrates strong operational efficiency with 20.2% ROE and robust free cash flow generation of $404.2M, but revenue and earnings stagnation (+0.0% YoY) signal limited organic growth prospects. Tight working capital position (1.07x current ratio) presents liquidity risk in a capital-intensive healthcare sector.

Why Buy PACS Group, Inc. Stock? PACS Key Strengths

Claude
  • + Excellent return on equity (20.2%) indicates highly efficient capital deployment and shareholder value creation
  • + Strong free cash flow generation ($404.2M annually, 7.6% FCF margin) demonstrates consistent cash conversion ability
  • + Moderate leverage (0.37x Debt/Equity) provides balance sheet flexibility and financial stability for capital-intensive operations

PACS Stock Risks: PACS Group, Inc. Investment Risks

Claude
  • ! Complete revenue stagnation (0.0% YoY) on $5.3B base indicates market maturity and absence of organic growth drivers
  • ! Critically tight liquidity position (1.07x current ratio) leaves minimal operational buffer for disruptions or strategic investments
  • ! Missing capital expenditure disclosure obscures true free cash flow quality and unmet facility upgrade/maintenance needs in aging care sector

Key Metrics to Watch

Claude
  • * Revenue growth rate acceleration - current 0% growth is unsustainable for equity value creation
  • * Working capital trends and current ratio recovery - liquidity cushion deterioration signals distress risk
  • * Actual capital expenditure requirements and disclosure - critical to validate reported free cash flow sustainability

PACS Group, Inc. (PACS) Financial Metrics & Key Ratios

Revenue
$5.3B
Net Income
$191.5M
EPS (Diluted)
$1.22
Free Cash Flow
$404.2M
Total Assets
$5.6B
Cash Position
$197.0M

💡 AI Analyst Insight

PACS Group, Inc. presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.

PACS Profit Margin, ROE & Profitability Analysis

Gross Margin N/A
Operating Margin 5.9%
Net Margin 3.6%
ROE 20.2%
ROA 3.4%
FCF Margin 7.6%

PACS vs Services Sector: How PACS Group, Inc. Compares

How PACS Group, Inc. compares to Services sector averages

Net Margin
PACS 3.6%
vs
Sector Avg 10.0%
PACS Sector
ROE
PACS 20.2%
vs
Sector Avg 16.0%
PACS Sector
Current Ratio
PACS 1.1x
vs
Sector Avg 1.5x
PACS Sector
Debt/Equity
PACS 0.4x
vs
Sector Avg 0.7x
PACS Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

Is PACS Group, Inc. Stock Overvalued? PACS Valuation Analysis 2026

Based on fundamental analysis, PACS Group, Inc. has mixed fundamental signals relative to the Services sector in 2026.

Return on Equity
20.2%
Sector avg: 16%
Net Profit Margin
3.6%
Sector avg: 10%
Revenue Growth
N/A
Year-over-year
Debt/Equity
0.37x
Sector avg: 0.7x

Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.

PACS Group, Inc. Balance Sheet: PACS Debt, Cash & Liquidity

Current Ratio
1.07x
Quick Ratio
1.07x
Debt/Equity
0.37x
Debt/Assets
82.9%
Interest Coverage
N/A
Long-term Debt
$353.2M

PACS Revenue & Earnings Growth: 5-Year Financial Trend

PACS 5-year financial data: Year 2024: Revenue $4.1B, Net Income $150.5M, EPS $1.17. Year 2025: Revenue $5.3B, Net Income $112.9M, EPS $0.88.
Revenue
Net Income
EPS (right axis)

5-Year Trend Summary: PACS Group, Inc.'s revenue has grown significantly by 29% over the 5-year period, indicating strong business expansion. The most recent EPS of $0.88 reflects profitable operations.

PACS Revenue Growth, EPS Growth & YoY Performance

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
7.6%
Free cash flow / Revenue

PACS Quarterly Earnings & Performance

Quarterly financial performance data for PACS Group, Inc. including revenue, net income, and earnings per share.
Quarter Revenue Net Income EPS
Q3 2025 $1.0B $15.6M $0.10
Q2 2025 $935.3M $2.9M $0.02
Q1 2025 $919.4M $28.5M $0.17
Q3 2024 $788.9M $15.6M $0.10
Q2 2024 $760.4M -$10.9M $-0.07
Q1 2024 $707.8M $37.6M $0.29

Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.

PACS Group, Inc. Dividends, Buybacks & Capital Allocation

Operating Cash Flow
$404.2M
Cash generated from operations
Dividends
None
No dividend program

PACS SEC Filings: Latest 10-K & 10-Q Analysis

Access official SEC EDGAR filings for PACS Group, Inc. (CIK: 0002001184)

📋 Recent SEC Filings

Date Form Document Action
Mar 26, 2026 4 xslF345X06/wk-form4_1774563293.xml View →
Mar 26, 2026 4 xslF345X06/wk-form4_1774563264.xml View →
Mar 26, 2026 4 xslF345X06/wk-form4_1774563220.xml View →
Mar 26, 2026 4 xslF345X06/wk-form4_1774563174.xml View →
Mar 26, 2026 4 xslF345X06/wk-form4_1774563132.xml View →

Frequently Asked Questions about PACS

What is the AI rating for PACS?

PACS Group, Inc. (PACS) has an AI rating of HOLD with 65% confidence, based on fundamental analysis of SEC EDGAR filings.

What are PACS's key strengths?

Claude: Excellent return on equity (20.2%) indicates highly efficient capital deployment and shareholder value creation. Strong free cash flow generation ($404.2M annually, 7.6% FCF margin) demonstrates consistent cash conversion ability.

What are the risks of investing in PACS?

Claude: Complete revenue stagnation (0.0% YoY) on $5.3B base indicates market maturity and absence of organic growth drivers. Critically tight liquidity position (1.07x current ratio) leaves minimal operational buffer for disruptions or strategic investments.

What is PACS's revenue and growth?

PACS Group, Inc. reported revenue of $5.3B.

Does PACS pay dividends?

PACS Group, Inc. does not currently pay dividends.

Where can I find PACS SEC filings?

Official SEC filings for PACS Group, Inc. (CIK: 0002001184) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is PACS's EPS?

PACS Group, Inc. has a diluted EPS of $1.22.

How is the AI analysis conducted?

Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.

Is PACS a good stock to buy right now?

Based on our AI fundamental analysis in April 2026, PACS Group, Inc. has a HOLD rating with 65% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.

Is PACS stock overvalued or undervalued?

Valuation metrics for PACS: ROE of 20.2% (sector avg: 16%), net margin of 3.6% (sector avg: 10%). Higher ROE suggests strong returns relative to peers.

Should I buy PACS stock in 2026?

Our dual AI analysis gives PACS Group, Inc. a combined HOLD rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.

What is PACS's free cash flow?

PACS Group, Inc.'s operating cash flow is $404.2M, with capital expenditures of N/A. FCF margin is 7.6%.

How does PACS compare to other Services stocks?

Vs Services sector averages: Net margin 3.6% (avg: 10%), ROE 20.2% (avg: 16%), current ratio 1.07 (avg: 1.5).

Top Rated Stocks
NSSC 92% MLI 92% MELI 92% MDXG 92% MANH 92% INVA 92% GGG 92% GCT 92% FTNT 92% FSLR 92%
Browse: High ROE Stocks
Disclaimer: This analysis is generated by Claude AI (Anthropic) and ChatGPT (OpenAI) based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Apr 13, 2026 | Data as of: 2025-12-31 | Powered by Claude AI